Healthcare providers across the country—and even in much of the world—are under enormous pressure to reduce costs and improve care quality. It’s likely no surprise that cardiac imaging is being especially scrutinized—with multiple initiatives under way to reduce and eliminate inappropriate testing.
In 2010, the cost of cardiovascular disease (CVD) in the U.S., including healthcare expenditures and lost productivity from death and disability, totaled more than $503 billion. Of this, more than 65 percent, or $325 billion, was attributed to direct medical costs.
Comments